# A Phase 1, Open-Label, PET Study of T2310 & BPN14770

> **NCT04044781** · PHASE1 · WITHDRAWN · sponsor: **Tetra Discovery Partners**

## Conditions studied

- To Determine Brain Target Occupancy of BPN14770

## Interventions

- **DRUG:** BPN14770, T2310

## Key facts

- **NCT ID:** NCT04044781
- **Lead sponsor:** Tetra Discovery Partners
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01-10
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-05-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in Research Direction
- **Last updated:** 2022-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04044781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04044781, "A Phase 1, Open-Label, PET Study of T2310 & BPN14770". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04044781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*